A circadian rhythm-related lncRNA signature correlates with prognosis and tumor immune microenvironment in head and neck squamous cell carcinoma

被引:1
作者
Zheng, Hongyu [1 ]
Li, Qiuyue [2 ]
Yang, Kai [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Dept Emergency Med, 23 Pingjiang Rd, Tianjin 300211, Peoples R China
关键词
Circadian rhythm; lncRNA; Squamous cell carcinoma; Prognostic signature; Immune microenvironment; PROGRESSION; CANCER;
D O I
10.1007/s12672-024-01181-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo investigate circadian rhythm-associated long non-coding RNA (lncRNA) signatures in predicting prognosis, metabolism, and immune infiltration in Head and Neck Squamous Cell Carcinoma (HNSC).MethodsHNSC samples were collected from the TCGA database. A signature was constructed using Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) methods. The immune cell infiltration was analyzed using CIBERSORT, ssGSEA, and MCPcounter. The RT-qPCR was used to detect the expression of signature lncRNAs.ResultsA signature comprising 8 lncRNAs was constructed. The constructed signature demonstrated good prognostic prediction capability for HNSC. A nomogram encompassing risk score accurately predicted the long-term OS probability of HNSC. The infiltration levels of T cell, B cell and Macrophages were significantly higher in the high-risk group than in the low-risk group. Cluster analysis showed that the signature lncRNAs could classify the HNSC samples into two clusters. The RT-qPCR suggested that the expression of lncRNAs in signature was consistent with the data in TCGA.ConclusionThe circadian rhythm-associated lncRNA signature has potential as a prognostic indicator for HNSC. It exhibits associations with metabolism, immune microenvironment, and drug sensitivity, thereby providing valuable insights for informing the treatment of HNSC.
引用
收藏
页数:19
相关论文
共 50 条
[1]   Circadian Rhythms Implications for Health and Disease [J].
Abbott, Sabra M. ;
Zee, Phyllis C. .
NEUROLOGIC CLINICS, 2019, 37 (03) :601-+
[2]   Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas [J].
Baumeister, Philipp ;
Zhou, Jiefu ;
Canis, Martin ;
Gires, Olivier .
CANCERS, 2021, 13 (21)
[3]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[4]   The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma [J].
Bueno-Urquiza, Lesly J. ;
Martinez-Barajas, Marcela G. ;
Villegas-Mercado, Carlos E. ;
Garcia-Bernal, Jonathan R. ;
Pereira-Suarez, Ana L. ;
Aguilar-Medina, Maribel ;
Bermudez, Mercedes .
CELLS, 2023, 12 (05)
[5]   Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer [J].
Caponio, Vito Carlo Alberto ;
Troiano, Giuseppe ;
Adipietro, Iolanda ;
Zhurakivska, Khrystyna ;
Arena, Claudia ;
Mangieri, Domenica ;
Mascitti, Marco ;
Cirillo, Nicola ;
Lo Muzio, Lorenzo .
BRITISH JOURNAL OF CANCER, 2020, 123 (08) :1302-1314
[6]  
De Lima PO, 2014, ANTICANCER RES, V34, P605
[7]   LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma [J].
Deng, Wei-Wei ;
Mao, Liang ;
Yu, Guang-Tao ;
Bu, Lin-Lin ;
Ma, Si-Rui ;
Liu, Bing ;
Gutkind, J. Silvio ;
Kulkarni, Ashok B. ;
Zhang, Wen-Feng ;
Sun, Zhi-Jun .
ONCOIMMUNOLOGY, 2016, 5 (11)
[8]   The contributory role of long non-coding RNAs (lncRNAs) in head and neck cancers: Possible biomarkers and therapeutic targets? [J].
Dilmaghani, Nader Akbari ;
Khoshsirat, Shahrokh ;
Shanaki-Bavarsad, Mahsa ;
Pourbagheri-Sigaroodi, Atieh ;
Bashash, Davood .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 900
[9]   Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma [J].
Ding, Zhao ;
Li, Hefeng ;
Yu, Deshun .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (10) :3973-3983
[10]   Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes [J].
Feng, Chunyu ;
Liu, Shaopeng ;
Shang, Zhengjun .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9